View in EDS HTML Full Text PDF Full Text

Nimotuzumab combined with docetaxel and cisplatin as first-line treatment for patients with recurrent or metastatic nasopharyngeal carcinoma: a multicenter, phase 2 trial.

Saved in:
Bibliographic Details
Title: Nimotuzumab combined with docetaxel and cisplatin as first-line treatment for patients with recurrent or metastatic nasopharyngeal carcinoma: a multicenter, phase 2 trial.
Authors: Zou, Qihua1,2 (AUTHOR), Cao, Yi1,2 (AUTHOR), Lai, Yulin1,2 (AUTHOR), Fang, Yu3,4 (AUTHOR), Zhang, Yuchen1,2 (AUTHOR), Liu, Panpan1,2 (AUTHOR), Lu, Lixia1,5 (AUTHOR), Wu, Hao6 (AUTHOR), Huang, Tianying7 (AUTHOR), Su, Ning8 (AUTHOR), Li, Zhihua3,4 (AUTHOR), Wang, Xicheng9 (AUTHOR), Tian, Xiaopeng1,2 (AUTHOR), Li, Lirong1,2 (AUTHOR), Liu, Yingxian1,2 (AUTHOR), Cai, Qingqing1,2 (AUTHOR) caiqq@sysucc.org.cn, Xia, Yi1,2 (AUTHOR) xiayi@sysucc.org.cn
Source: BMC Medicine. 5/6/2025, Vol. 23 Issue 1, p1-11. 11p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 184953049
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Nimotuzumab combined with docetaxel and cisplatin as first-line treatment for patients with recurrent or metastatic nasopharyngeal carcinoma: a multicenter, phase 2 trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Zou%2C+Qihua%22">Zou, Qihua</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cao%2C+Yi%22">Cao, Yi</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lai%2C+Yulin%22">Lai, Yulin</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Fang%2C+Yu%22">Fang, Yu</searchLink><relatesTo>3,4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhang%2C+Yuchen%22">Zhang, Yuchen</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liu%2C+Panpan%22">Liu, Panpan</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lu%2C+Lixia%22">Lu, Lixia</searchLink><relatesTo>1,5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wu%2C+Hao%22">Wu, Hao</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Huang%2C+Tianying%22">Huang, Tianying</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Su%2C+Ning%22">Su, Ning</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Li%2C+Zhihua%22">Li, Zhihua</searchLink><relatesTo>3,4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Xicheng%22">Wang, Xicheng</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tian%2C+Xiaopeng%22">Tian, Xiaopeng</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Li%2C+Lirong%22">Li, Lirong</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liu%2C+Yingxian%22">Liu, Yingxian</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cai%2C+Qingqing%22">Cai, Qingqing</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<i> caiqq@sysucc.org.cn</i><br /><searchLink fieldCode="AR" term="%22Xia%2C+Yi%22">Xia, Yi</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<i> xiayi@sysucc.org.cn</i>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22BMC+Medicine%22">BMC Medicine</searchLink>. 5/6/2025, Vol. 23 Issue 1, p1-11. 11p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=184953049
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s12916-025-04103-0
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 11
        StartPage: 1
    Titles:
      – TitleFull: Nimotuzumab combined with docetaxel and cisplatin as first-line treatment for patients with recurrent or metastatic nasopharyngeal carcinoma: a multicenter, phase 2 trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Zou, Qihua
      – PersonEntity:
          Name:
            NameFull: Cao, Yi
      – PersonEntity:
          Name:
            NameFull: Lai, Yulin
      – PersonEntity:
          Name:
            NameFull: Fang, Yu
      – PersonEntity:
          Name:
            NameFull: Zhang, Yuchen
      – PersonEntity:
          Name:
            NameFull: Liu, Panpan
      – PersonEntity:
          Name:
            NameFull: Lu, Lixia
      – PersonEntity:
          Name:
            NameFull: Wu, Hao
      – PersonEntity:
          Name:
            NameFull: Huang, Tianying
      – PersonEntity:
          Name:
            NameFull: Su, Ning
      – PersonEntity:
          Name:
            NameFull: Li, Zhihua
      – PersonEntity:
          Name:
            NameFull: Wang, Xicheng
      – PersonEntity:
          Name:
            NameFull: Tian, Xiaopeng
      – PersonEntity:
          Name:
            NameFull: Li, Lirong
      – PersonEntity:
          Name:
            NameFull: Liu, Yingxian
      – PersonEntity:
          Name:
            NameFull: Cai, Qingqing
      – PersonEntity:
          Name:
            NameFull: Xia, Yi
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 06
              M: 05
              Text: 5/6/2025
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 17417015
          Numbering:
            – Type: volume
              Value: 23
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: BMC Medicine
              Type: main
ResultId 1